Pancreatic Cancer Diagnostic Market - Global Outlook and Forecast 2021-2027

March 2021 | 94 pages | ID: P4540F2696DBEN
Market Monitor Global

Abstracts

This report contains market size and forecasts of Pancreatic Cancer Diagnostic in Global, including the following market information:

Global Pancreatic Cancer Diagnostic Market Revenue, 2016-2021, 2022-2027, ($ millions)

Global top five companies in 2020 (%)

The global Pancreatic Cancer Diagnostic market was valued at 5410.7 million in 2020 and is projected to reach US$ 7139.5 million by 2027, at a CAGR of 7.2% during the forecast period.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Pancreatic Cancer Diagnostic companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Pancreatic Cancer Diagnostic Market, By Type, 2016-2021, 2022-2027 ($ millions)

Global Pancreatic Cancer Diagnostic Market Segment Percentages, By Type, 2020 (%)

• Imaging
• Tumor Biomarker
• Biopsy
• Other

China Pancreatic Cancer Diagnostic Market, By Application, 2016-2021, 2022-2027 ($ millions)

China Pancreatic Cancer Diagnostic Market Segment Percentages, By Application, 2020 (%)

• Hospitals
• Clinics
• Others

Global Pancreatic Cancer Diagnostic Market, By Region and Country, 2016-2021, 2022-2027 ($ Millions)

Global Pancreatic Cancer Diagnostic Market Segment Percentages, By Region and Country, 2020 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Total Pancreatic Cancer Diagnostic Market Competitors Revenues in Global, by Players 2016-2021 (Estimated), ($ millions)

Total Pancreatic Cancer Diagnostic Market Competitors Revenues Share in Global, by Players 2020 (%)

Further, the report presents profiles of competitors in the market, including the following:

• Siemens
• GE Healthcare
• Roche
• Philips Healthcare
• Danaher
• Canon Medical Systems
• Abbott
• Hitachi Medical
• Qiagen
• Myriad Genetics

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Pancreatic Cancer Diagnostic Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Pancreatic Cancer Diagnostic Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL PANCREATIC CANCER DIAGNOSTIC OVERALL MARKET SIZE

2.1 Global Pancreatic Cancer Diagnostic Market Size: 2021 VS 2027
2.2 Global Pancreatic Cancer Diagnostic Market Size, Prospects & Forecasts: 2016-2027
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Pancreatic Cancer Diagnostic Players in Global Market
3.2 Top Global Pancreatic Cancer Diagnostic Companies Ranked by Revenue
3.3 Global Pancreatic Cancer Diagnostic Revenue by Companies
3.4 Top 3 and Top 5 Pancreatic Cancer Diagnostic Companies in Global Market, by Revenue in 2020
3.5 Global Companies Pancreatic Cancer Diagnostic Product Type
3.6 Tier 1, Tier 2 and Tier 3 Pancreatic Cancer Diagnostic Players in Global Market
  3.6.1 List of Global Tier 1 Pancreatic Cancer Diagnostic Companies
  3.6.2 List of Global Tier 2 and Tier 3 Pancreatic Cancer Diagnostic Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 By Type - Global Pancreatic Cancer Diagnostic Market Size Markets, 2021 & 2027
  4.1.2 Imaging
  4.1.3 Tumor Biomarker
  4.1.4 Biopsy
  4.1.5 Other
4.2 By Type - Global Pancreatic Cancer Diagnostic Revenue & Forecasts
  4.2.1 By Type - Global Pancreatic Cancer Diagnostic Revenue, 2016-2021
  4.2.2 By Type - Global Pancreatic Cancer Diagnostic Revenue, 2022-2027
  4.2.3 By Type - Global Pancreatic Cancer Diagnostic Revenue Market Share, 2016-2027

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Pancreatic Cancer Diagnostic Market Size, 2021 & 2027
  5.1.2 Hospitals
  5.1.3 Clinics
  5.1.4 Others
5.2 By Application - Global Pancreatic Cancer Diagnostic Revenue & Forecasts
  5.2.1 By Application - Global Pancreatic Cancer Diagnostic Revenue, 2016-2021
  5.2.2 By Application - Global Pancreatic Cancer Diagnostic Revenue, 2022-2027
  5.2.3 By Application - Global Pancreatic Cancer Diagnostic Revenue Market Share, 2016-2027

6 SIGHTS BY REGION

6.1 By Region - Global Pancreatic Cancer Diagnostic Market Size, 2021 & 2027
6.2 By Region - Global Pancreatic Cancer Diagnostic Revenue & Forecasts
  6.2.1 By Region - Global Pancreatic Cancer Diagnostic Revenue, 2016-2021
  6.2.2 By Region - Global Pancreatic Cancer Diagnostic Revenue, 2022-2027
  6.2.3 By Region - Global Pancreatic Cancer Diagnostic Revenue Market Share, 2016-2027
6.3 North America
  6.3.1 By Country - North America Pancreatic Cancer Diagnostic Revenue, 2016-2027
  6.3.2 US Pancreatic Cancer Diagnostic Market Size, 2016-2027
  6.3.3 Canada Pancreatic Cancer Diagnostic Market Size, 2016-2027
  6.3.4 Mexico Pancreatic Cancer Diagnostic Market Size, 2016-2027
6.4 Europe
  6.4.1 By Country - Europe Pancreatic Cancer Diagnostic Revenue, 2016-2027
  6.4.2 Germany Pancreatic Cancer Diagnostic Market Size, 2016-2027
  6.4.3 France Pancreatic Cancer Diagnostic Market Size, 2016-2027
  6.4.4 U.K. Pancreatic Cancer Diagnostic Market Size, 2016-2027
  6.4.5 Italy Pancreatic Cancer Diagnostic Market Size, 2016-2027
  6.4.6 Russia Pancreatic Cancer Diagnostic Market Size, 2016-2027
  6.4.7 Nordic Countries Pancreatic Cancer Diagnostic Market Size, 2016-2027
  6.4.8 Benelux Pancreatic Cancer Diagnostic Market Size, 2016-2027
6.5 Asia
  6.5.1 By Region - Asia Pancreatic Cancer Diagnostic Revenue, 2016-2027
  6.5.2 China Pancreatic Cancer Diagnostic Market Size, 2016-2027
  6.5.3 Japan Pancreatic Cancer Diagnostic Market Size, 2016-2027
  6.5.4 South Korea Pancreatic Cancer Diagnostic Market Size, 2016-2027
  6.5.5 Southeast Asia Pancreatic Cancer Diagnostic Market Size, 2016-2027
  6.5.6 India Pancreatic Cancer Diagnostic Market Size, 2016-2027
6.6 South America
  6.6.1 By Country - South America Pancreatic Cancer Diagnostic Revenue, 2016-2027
  6.6.2 Brazil Pancreatic Cancer Diagnostic Market Size, 2016-2027
  6.6.3 Argentina Pancreatic Cancer Diagnostic Market Size, 2016-2027
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Pancreatic Cancer Diagnostic Revenue, 2016-2027
  6.7.2 Turkey Pancreatic Cancer Diagnostic Market Size, 2016-2027
  6.7.3 Israel Pancreatic Cancer Diagnostic Market Size, 2016-2027
  6.7.4 Saudi Arabia Pancreatic Cancer Diagnostic Market Size, 2016-2027
  6.7.5 UAE Pancreatic Cancer Diagnostic Market Size, 2016-2027

7 PLAYERS PROFILES

7.1 Siemens
  7.1.1 Siemens Corporate Summary
  7.1.2 Siemens Business Overview
  7.1.3 Siemens Pancreatic Cancer Diagnostic Major Product Offerings
  7.1.4 Siemens Pancreatic Cancer Diagnostic Revenue in Global (2016-2021)
  7.1.5 Siemens Key News
7.2 GE Healthcare
  7.2.1 GE Healthcare Corporate Summary
  7.2.2 GE Healthcare Business Overview
  7.2.3 GE Healthcare Pancreatic Cancer Diagnostic Major Product Offerings
  7.2.4 GE Healthcare Pancreatic Cancer Diagnostic Revenue in Global (2016-2021)
  7.2.5 GE Healthcare Key News
7.3 Roche
  7.3.1 Roche Corporate Summary
  7.3.2 Roche Business Overview
  7.3.3 Roche Pancreatic Cancer Diagnostic Major Product Offerings
  7.3.4 Roche Pancreatic Cancer Diagnostic Revenue in Global (2016-2021)
  7.3.5 Roche Key News
7.4 Philips Healthcare
  7.4.1 Philips Healthcare Corporate Summary
  7.4.2 Philips Healthcare Business Overview
  7.4.3 Philips Healthcare Pancreatic Cancer Diagnostic Major Product Offerings
  7.4.4 Philips Healthcare Pancreatic Cancer Diagnostic Revenue in Global (2016-2021)
  7.4.5 Philips Healthcare Key News
7.5 Danaher
  7.5.1 Danaher Corporate Summary
  7.5.2 Danaher Business Overview
  7.5.3 Danaher Pancreatic Cancer Diagnostic Major Product Offerings
  7.5.4 Danaher Pancreatic Cancer Diagnostic Revenue in Global (2016-2021)
  7.5.5 Danaher Key News
7.6 Canon Medical Systems
  7.6.1 Canon Medical Systems Corporate Summary
  7.6.2 Canon Medical Systems Business Overview
  7.6.3 Canon Medical Systems Pancreatic Cancer Diagnostic Major Product Offerings
  7.6.4 Canon Medical Systems Pancreatic Cancer Diagnostic Revenue in Global (2016-2021)
  7.6.5 Canon Medical Systems Key News
7.7 Abbott
  7.7.1 Abbott Corporate Summary
  7.7.2 Abbott Business Overview
  7.7.3 Abbott Pancreatic Cancer Diagnostic Major Product Offerings
  7.4.4 Abbott Pancreatic Cancer Diagnostic Revenue in Global (2016-2021)
  7.7.5 Abbott Key News
7.8 Hitachi Medical
  7.8.1 Hitachi Medical Corporate Summary
  7.8.2 Hitachi Medical Business Overview
  7.8.3 Hitachi Medical Pancreatic Cancer Diagnostic Major Product Offerings
  7.8.4 Hitachi Medical Pancreatic Cancer Diagnostic Revenue in Global (2016-2021)
  7.8.5 Hitachi Medical Key News
7.9 Qiagen
  7.9.1 Qiagen Corporate Summary
  7.9.2 Qiagen Business Overview
  7.9.3 Qiagen Pancreatic Cancer Diagnostic Major Product Offerings
  7.9.4 Qiagen Pancreatic Cancer Diagnostic Revenue in Global (2016-2021)
  7.9.5 Qiagen Key News
7.10 Myriad Genetics
  7.10.1 Myriad Genetics Corporate Summary
  7.10.2 Myriad Genetics Business Overview
  7.10.3 Myriad Genetics Pancreatic Cancer Diagnostic Major Product Offerings
  7.10.4 Myriad Genetics Pancreatic Cancer Diagnostic Revenue in Global (2016-2021)
  7.10.5 Myriad Genetics Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Pancreatic Cancer Diagnostic Market Opportunities & Trends in Global Market
Table 2. Pancreatic Cancer Diagnostic Market Drivers in Global Market
Table 3. Pancreatic Cancer Diagnostic Market Restraints in Global Market
Table 4. Key Players of Pancreatic Cancer Diagnostic in Global Market
Table 5. Top Pancreatic Cancer Diagnostic Players in Global Market, Ranking by Revenue (2019)
Table 6. Global Pancreatic Cancer Diagnostic Revenue by Companies, (US$, Mn), 2016-2021
Table 7. Global Pancreatic Cancer Diagnostic Revenue Share by Companies, 2016-2021
Table 8. Global Companies Pancreatic Cancer Diagnostic Product Type
Table 9. List of Global Tier 1 Pancreatic Cancer Diagnostic Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Pancreatic Cancer Diagnostic Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type – Global Pancreatic Cancer Diagnostic Revenue, (US$, Mn), 2021 VS 2027
Table 12. By Type - Pancreatic Cancer Diagnostic Revenue in Global (US$, Mn), 2016-2021
Table 13. By Type - Pancreatic Cancer Diagnostic Revenue in Global (US$, Mn), 2022-2027
Table 14. By Application – Global Pancreatic Cancer Diagnostic Revenue, (US$, Mn), 2021 VS 2027
Table 15. By Application - Pancreatic Cancer Diagnostic Revenue in Global (US$, Mn), 2016-2021
Table 16. By Application - Pancreatic Cancer Diagnostic Revenue in Global (US$, Mn), 2022-2027
Table 17. By Region – Global Pancreatic Cancer Diagnostic Revenue, (US$, Mn), 2021 VS 2027
Table 18. By Region - Global Pancreatic Cancer Diagnostic Revenue (US$, Mn), 2016-2021
Table 19. By Region - Global Pancreatic Cancer Diagnostic Revenue (US$, Mn), 2022-2027
Table 20. By Country - North America Pancreatic Cancer Diagnostic Revenue, (US$, Mn), 2016-2021
Table 21. By Country - North America Pancreatic Cancer Diagnostic Revenue, (US$, Mn), 2022-2027
Table 22. By Country - Europe Pancreatic Cancer Diagnostic Revenue, (US$, Mn), 2016-2021
Table 23. By Country - Europe Pancreatic Cancer Diagnostic Revenue, (US$, Mn), 2022-2027
Table 24. By Region - Asia Pancreatic Cancer Diagnostic Revenue, (US$, Mn), 2016-2021
Table 25. By Region - Asia Pancreatic Cancer Diagnostic Revenue, (US$, Mn), 2022-2027
Table 26. By Country - South America Pancreatic Cancer Diagnostic Revenue, (US$, Mn), 2016-2021
Table 27. By Country - South America Pancreatic Cancer Diagnostic Revenue, (US$, Mn), 2022-2027
Table 28. By Country - Middle East & Africa Pancreatic Cancer Diagnostic Revenue, (US$, Mn), 2016-2021
Table 29. By Country - Middle East & Africa Pancreatic Cancer Diagnostic Revenue, (US$, Mn), 2022-2027
Table 30. Siemens Corporate Summary
Table 31. Siemens Pancreatic Cancer Diagnostic Product Offerings
Table 32. Siemens Pancreatic Cancer Diagnostic Revenue (US$, Mn), (2016-2021)
Table 33. GE Healthcare Corporate Summary
Table 34. GE Healthcare Pancreatic Cancer Diagnostic Product Offerings
Table 35. GE Healthcare Pancreatic Cancer Diagnostic Revenue (US$, Mn), (2016-2021)
Table 36. Roche Corporate Summary
Table 37. Roche Pancreatic Cancer Diagnostic Product Offerings
Table 38. Roche Pancreatic Cancer Diagnostic Revenue (US$, Mn), (2016-2021)
Table 39. Philips Healthcare Corporate Summary
Table 40. Philips Healthcare Pancreatic Cancer Diagnostic Product Offerings
Table 41. Philips Healthcare Pancreatic Cancer Diagnostic Revenue (US$, Mn), (2016-2021)
Table 42. Danaher Corporate Summary
Table 43. Danaher Pancreatic Cancer Diagnostic Product Offerings
Table 44. Danaher Pancreatic Cancer Diagnostic Revenue (US$, Mn), (2016-2021)
Table 45. Canon Medical Systems Corporate Summary
Table 46. Canon Medical Systems Pancreatic Cancer Diagnostic Product Offerings
Table 47. Canon Medical Systems Pancreatic Cancer Diagnostic Revenue (US$, Mn), (2016-2021)
Table 48. Abbott Corporate Summary
Table 49. Abbott Pancreatic Cancer Diagnostic Product Offerings
Table 50. Abbott Pancreatic Cancer Diagnostic Revenue (US$, Mn), (2016-2021)
Table 51. Hitachi Medical Corporate Summary
Table 52. Hitachi Medical Pancreatic Cancer Diagnostic Product Offerings
Table 53. Hitachi Medical Pancreatic Cancer Diagnostic Revenue (US$, Mn), (2016-2021)
Table 54. Qiagen Corporate Summary
Table 55. Qiagen Pancreatic Cancer Diagnostic Product Offerings
Table 56. Qiagen Pancreatic Cancer Diagnostic Revenue (US$, Mn), (2016-2021)
Table 57. Myriad Genetics Corporate Summary
Table 58. Myriad Genetics Pancreatic Cancer Diagnostic Product Offerings
Table 59. Myriad Genetics Pancreatic Cancer Diagnostic Revenue (US$, Mn), (2016-2021)

List Of Figures

LIST OF FIGURES

Figure 1. Pancreatic Cancer Diagnostic Segment by Type
Figure 2. Pancreatic Cancer Diagnostic Segment by Application
Figure 3. Global Pancreatic Cancer Diagnostic Market Overview: 2020
Figure 4. Key Caveats
Figure 5. Global Pancreatic Cancer Diagnostic Market Size: 2021 VS 2027 (US$, Mn)
Figure 6. Global Pancreatic Cancer Diagnostic Revenue, 2016-2027 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Pancreatic Cancer Diagnostic Revenue in 2020
Figure 8. By Type - Global Pancreatic Cancer Diagnostic Revenue Market Share, 2016-2027
Figure 9. By Application - Global Pancreatic Cancer Diagnostic Revenue Market Share, 2016-2027
Figure 10. By Region - Global Pancreatic Cancer Diagnostic Revenue Market Share, 2016-2027
Figure 11. By Country - North America Pancreatic Cancer Diagnostic Revenue Market Share, 2016-2027
Figure 12. US Pancreatic Cancer Diagnostic Revenue, (US$, Mn), 2016-2027
Figure 13. Canada Pancreatic Cancer Diagnostic Revenue, (US$, Mn), 2016-2027
Figure 14. Mexico Pancreatic Cancer Diagnostic Revenue, (US$, Mn), 2016-2027
Figure 15. By Country - Europe Pancreatic Cancer Diagnostic Revenue Market Share, 2016-2027
Figure 16. Germany Pancreatic Cancer Diagnostic Revenue, (US$, Mn), 2016-2027
Figure 17. France Pancreatic Cancer Diagnostic Revenue, (US$, Mn), 2016-2027
Figure 18. U.K. Pancreatic Cancer Diagnostic Revenue, (US$, Mn), 2016-2027
Figure 19. Italy Pancreatic Cancer Diagnostic Revenue, (US$, Mn), 2016-2027
Figure 20. Russia Pancreatic Cancer Diagnostic Revenue, (US$, Mn), 2016-2027
Figure 21. Nordic Countries Pancreatic Cancer Diagnostic Revenue, (US$, Mn), 2016-2027
Figure 22. Benelux Pancreatic Cancer Diagnostic Revenue, (US$, Mn), 2016-2027
Figure 23. By Region - Asia Pancreatic Cancer Diagnostic Revenue Market Share, 2016-2027
Figure 24. China Pancreatic Cancer Diagnostic Revenue, (US$, Mn), 2016-2027
Figure 25. Japan Pancreatic Cancer Diagnostic Revenue, (US$, Mn), 2016-2027
Figure 26. South Korea Pancreatic Cancer Diagnostic Revenue, (US$, Mn), 2016-2027
Figure 27. Southeast Asia Pancreatic Cancer Diagnostic Revenue, (US$, Mn), 2016-2027
Figure 28. India Pancreatic Cancer Diagnostic Revenue, (US$, Mn), 2016-2027
Figure 29. By Country - South America Pancreatic Cancer Diagnostic Revenue Market Share, 2016-2027
Figure 30. Brazil Pancreatic Cancer Diagnostic Revenue, (US$, Mn), 2016-2027
Figure 31. Argentina Pancreatic Cancer Diagnostic Revenue, (US$, Mn), 2016-2027
Figure 32. By Country - Middle East & Africa Pancreatic Cancer Diagnostic Revenue Market Share, 2016-2027
Figure 33. Turkey Pancreatic Cancer Diagnostic Revenue, (US$, Mn), 2016-2027
Figure 34. Israel Pancreatic Cancer Diagnostic Revenue, (US$, Mn), 2016-2027
Figure 35. Saudi Arabia Pancreatic Cancer Diagnostic Revenue, (US$, Mn), 2016-2027
Figure 36. UAE Pancreatic Cancer Diagnostic Revenue, (US$, Mn), 2016-2027
Figure 37. Siemens Pancreatic Cancer Diagnostic Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 38. GE Healthcare Pancreatic Cancer Diagnostic Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 39. Roche Pancreatic Cancer Diagnostic Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 40. Philips Healthcare Pancreatic Cancer Diagnostic Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 41. Danaher Pancreatic Cancer Diagnostic Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 42. Canon Medical Systems Pancreatic Cancer Diagnostic Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 43. Abbott Pancreatic Cancer Diagnostic Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 44. Hitachi Medical Pancreatic Cancer Diagnostic Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 45. Qiagen Pancreatic Cancer Diagnostic Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 46. Myriad Genetics Pancreatic Cancer Diagnostic Revenue Year Over Year Growth (US$, Mn) & (2016-2021)